Abbott Recalls HeartMate LVAS For Obstruction Issue
Abbott is recalling its HeartMate II and 3 LVAS due to Extrinsic Outflow Graft Obstruction, which can lead to severe health risks or death.
Read MoreAbbott is recalling its HeartMate II and 3 LVAS due to Extrinsic Outflow Graft Obstruction, which can lead to severe health risks or death.
Read MoreScott Lucas, PhD, PE, vice president of device safety at ECRI, talks about how skin tone affects pulse oximeters and racial inequity in healthcare.
Read MoreMar 27, 2024 | Draft Guidances, Medical Equipment | 0 |
The U.S. FDA has proposed banning electrical stimulation devices for self-injurious or aggressive behavior due to significant risks, marking the second attempt at prohibition, with implications including potential treatment transitions for users and a thorough review of updated evidence and expert opinions.
Read MoreMar 12, 2024 | Patient Safety | 0 |
Challenges transitioning new clinicians from academic training to professional practice tops ECRI’s 2024 list of 10 patient safety concerns.
Read MoreWhile most CMMS partners offer nearly the same features and functionality, it’s up to the HTM shop to maximize their potential.
Read More